Investigating Interventions to Reduce Residual Opioids in the Home Following Legitimate Opioid Prescribing in Children.
Investigating the Impact of Formal Interventions on Reducing Residual Opioids in the Home Following Legitimate Prescribing for Acute Post-surgical Pain in Pediatric Patients.
1 other identifier
interventional
83
1 country
2
Brief Summary
The overall objective of this study is to evaluate strategies to reduce unused opioids prescribed for pediatric acute post-surgical pain management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2020
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2019
CompletedFirst Posted
Study publicly available on registry
January 7, 2020
CompletedStudy Start
First participant enrolled
January 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 3, 2023
CompletedFebruary 15, 2024
February 1, 2024
2.9 years
December 13, 2019
February 14, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Quantification of residual opioids.
Identify if there are left over opioid medications following completion of analgesic therapy, and if so, how many?
Post-discharge days 8-10
Assess participation in medication take back through follow up phone interview questionnaire.
Assess the degree of participation in medication take back programs to dispose of any residual opioid medications following completion of analgesic therapy.
Post-discharge days 8-10
Assess participation in medication home disposal through follow up phone interview questionnaire.
Assess the degree of participation in medication home disposal to dispose of any residual opioid medications following completion of analgesic therapy.
Post-discharge days 8-10
Secondary Outcomes (3)
Identify noncompliance/unsafe behaviors that contribute to retention of residual opioids through follow up phone interview questionnaire.
Post-discharge days 8-10
Average daily pain scores reported as values on Numerical Rating Scale.
Preoperatively through post-discharge day #10
Frequency of opioid consumption through follow up phone interview questionnaire.
Post-operative day 1 through post-discharge day 10
Other Outcomes (8)
Demographic data
preoperatively through post-discharge day 10
Post operative pain scores reported as a numerical value on the Numerical Rating Scale.
Post operative day zero through post-discharge day 10
Opioid consumption
Preoperatively through post-discharge day 10
- +5 more other outcomes
Study Arms (3)
Control
NO INTERVENTIONPatients in this group will receive usual care from the acute pain medicine service, and will go home with standardized multimodal analgesic protocol. There will be no interventions provided. They will receive a follow up phone call survey and be asked to return a completed medication education calendar that is provided as a part of usual APS care.
Medication take back education intervention
EXPERIMENTALPatients in this group will receive usual care from the acute pain medicine service, and will go home with standardized multimodal analgesic protocol as described in the control group. They will receive a standardized education intervention. This intervention will educate patients and their families about medication take back programs, and will provide tailored directions to the closest medication take back center from their home, and also an option for medication take back that is located in close proximity to Riley Hospital clinics.
Home disposal kit intervention
EXPERIMENTALPatients in this group will receive usual care from the acute pain medicine service, and will go home with standardized multimodal analgesic protocol as described in the control group. They will receive standardized education about how to use the medication home disposal kit : Dispose Rx(r), and they will be instructed to use this kit to dispose of any left over opioid medications that they may have after they have competed therapy for pain management at home.
Interventions
Patients will be provided with formal education about medication take back programs for left-over prescription medications. They will be provided with directions to the closest medication take back facility to their home, and directions to the closet medication take back facility near their post-operative clinic site, and instructed to dispose of any left-over oxycodone medication (at completion of analgesic therapy) through participating in medication take back.
Patients and their families will be provided with formal education about how to use the medication home disposal kit: Dispose Rx, provided with a Dispose Rx home disposal kit, and instructed to dispose of any left-over oxycodone prescription medications with this kit following completion of analgesic therapy.
Eligibility Criteria
You may qualify if:
- Male or female children ages 12-17.9 years old
- ASA physical status 1 and 2
- Patients undergoing primary posterior spinal fusion surgery for correction of idiopathic scoliosis.
- Patients undergoing Nuss bar correction of pectus excavatum deformity.
You may not qualify if:
- Oxycodone allergy
- severe sleep apnea
- developmental delay
- neurological disorders
- liver disease/impairment
- renal disease/decreased renal function
- patients on opioid therapy prior to surgery
- Requires a translator for communication in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Indiana Universitylead
- The Society for Pediatric Anesthesiacollaborator
- LCMC Healthcollaborator
Study Sites (2)
Riley Hospital for Children/Indiana University
Indianapolis, Indiana, 46202, United States
Children's Hospital of New Orleans/ LCMC Health
New Orleans, Louisiana, 70118, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Michele A Hendrickson, MD,MS
Indiana University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Following patient enrollment, only the unblinded study coordinators will provide information and education to the patients/families about which arm they are randomized to. The investigator and other collaborators will conduct follow-up phone calls and data input and analysis in a blinded fashion.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 13, 2019
First Posted
January 7, 2020
Study Start
January 23, 2020
Primary Completion
January 3, 2023
Study Completion
January 3, 2023
Last Updated
February 15, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share